Jan Drappatz

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research communications

Journal of nursing measurement

This page only lists publications with an associated author ORCID identifier.

Publications

Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil D Dhruv, Yue Hao, Michael E Berens, Tobias Walbert, Matthias Holdhoff, Glenn J Lesser, Timothy F Cloughesy, Andrew E Sloan, Naoko Takebe, Marta Couce, David M Peereboom, Louis Burt Nabors, Patrick Yung Wen, Stuart A Grossman, Lisa R Rogers
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil D Dhruv, Yue Hao, Michael E Berens, Tobias Walbert, Matthias Holdhoff, Glenn J Lesser, Timothy F Cloughesy, Andrew E Sloan, Naoko Takebe, Marta Couce, David M Peereboom, Louis Burt Nabors, Patrick Yung Wen, Stuart A Grossman, Lisa R Rogers
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil D Dhruv, Yue Hao, Michael E Berens, Tobias Walbert, Matthias Holdhoff, Glenn J Lesser, Timothy F Cloughesy, Andrew E Sloan, Naoko Takebe, Marta Couce, David M Peereboom, Louis Burt Nabors, Patrick Yung Wen, Stuart A Grossman, Lisa R Rogers
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil D Dhruv, Yue Hao, Michael E Berens, Tobias Walbert, Matthias Holdhoff, Glenn J Lesser, Timothy F Cloughesy, Andrew E Sloan, Naoko Takebe, Marta Couce, David M Peereboom, Louis Burt Nabors, Patrick Yung Wen, Stuart A Grossman, Lisa R Rogers
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for Patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Manmeet S Ahluwalia, Ahmad Ozair, Jan Drappatz, Xiaobu Ye, Sen Peng, Matthew Lee, Sanhita Rath, Harshil D Dhruv, Yue Hao, Michael E Berens, Tobias Walbert, Matthias Holdhoff, Glenn J Lesser, Timothy F Cloughesy, Andrew E Sloan, Naoko Takebe, Marta Couce, David M Peereboom, Louis Burt Nabors, Patrick Yung Wen, Stuart A Grossman, Lisa R Rogers
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kristina A Fanucci, Mary Jo Pilat, Derek Shyr, Yu Shyr, Scott A Boerner, Jing Li, Diane E Durecki, Jan Drappatz, Vinay K Puduvalli, Frank Scott Lieberman, Javier Gonzalez, Pierre Giglio, Susan Percy Ivy, Ranjit S Bindra, Antonio Omuro, Patricia M LoRusso
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2 -mutant Glioma. Cancer research communications 3 (2) (2023)
Kristina A Fanucci, Mary Jo Pilat, Derek Shyr, Yu Shyr, Scott A Boerner, Jing Li, Diane E Durecki, Jan Drappatz, Vinay K Puduvalli, Frank Scott Lieberman, Javier Gonzalez, Pierre Giglio, Susan Percy Ivy, Ranjit S Bindra, Antonio Omuro, Patricia M LoRusso
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2 -mutant Glioma. Cancer research communications 3 (2) (2023)
Michal Nisnboym, Sarah R Vincze, Zujian Xiong, Chaim T Sneiderman, Rebecca A Raphael, Bo Li, Ambika P Jaswal, ReidAnn E Sever, Kathryn E Day, Joseph D LaToche, Lesley M Foley, Hanieh Karimi, T Kevin Hitchens, Sameer Agnihotri, Baoli Hu, Dhivyaa Rajasundaram, Carolyn J Anderson, Deborah T Blumenthal, Thomas M Pearce, Shikhar Uttam, Jessie R Nedrow, Ashok Panigrahy, Ian F Pollack, Frank Scott Lieberman, Jan Drappatz, Itay Raphael, Wilson B Edwards, Gary Kohanbash
Immuno-PET Imaging of CD69 Visualizes T-Cell Activation and Predicts Survival Following Immunotherapy in Murine Glioblastoma. Cancer research communications 3 (7) (2023)
Florien W Boele, Lauren Terhorst, Jennifer Prince, Heidi S Donovan, Jason Weimer, Paula R Sherwood, Frank S Lieberman, Jan Drappatz
Psychometric Evaluation of the Caregiver Needs Screen in Neuro-Oncology Family Caregivers. Journal of nursing measurement 27 (2) (2020)